Skip to main content
Signal8

IMMUNIC, INC. (IMUX)

Immunic, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to pioneering selective oral immunotherapies for a range of chronic inflammatory and autoimmune conditions. Its primary investigational compound, IMU-838, has advanced to Phase 2 clinical trials, targeting relapsing-remitting multiple sclerosis (RRMS), inflammatory bowel disease (IBD), various other chronic inflammatory and autoimmune disorders, and also coronavirus disease. Additionally, the company is advancing IMU-935, which functions as an inverse agonist of RORγt, and IMU-856, designed to restore the intestinal barrier for patients afflicted with conditions like inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor-induced colitis, and other ailments affecting intestinal barrier integrity. The company's headquarters are located in New York, New York.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Immunic, Inc. logo

Immunic, Inc.

NASDAQ:IMUXHealthcare
-3.66%$7.51
AH$7.62+1.46%vs close
Mkt Cap$102.47M
Float–
O/S13.64M
Vol
$ Vol
RVOL
Inst Own62.3%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$97.17M
Total Assets$24.05M
Free Cash Flow-$85.97M
Debt & Equity
Total Debt$684K
Total Equity-$6.67M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
2-year cumulative
1:10

Nasdaq bars a compliance period at 1:250

  1. 1:10Reverse split
    Apr 27, 202610 shares → 1
Balance Sheet Details
Assets$24.05M
Liabilities$30.73M
Accounts Receivable$4.12M
Accounts Payable$10.14M
Inventory$0
PP&E (Net)$1.18M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue$0$0$0$0$0$0$0$0$0$6K$0$0$0$0$0
YoY Growth---------------
Cost of Revenue$0$0$0$0$0$0$50K$15K$998K$1.81M$1.33M$0$0$0$0
Gross Profit$0$0$0$0$0$0-$50K-$15K-$998K-$1.8M-$1.33M$0$0$0$0
Gross Margin----------28529.7%-----
Research and Development$81.98M$80.05M$83.22M$71.25M$61.12M$38.64M$22.51M$24.82M$39.34M$30.05M$39.77M$39.48M$21.79M$5.1M$5.51M
Selling, General, and Administrative$21.25M$18.01M$16.01M$15.26M$13.3M$10.33M$14.52M$13.59M$13.31M$11.22M$12.35M$10.86M$9.62M$4.48M$3.07M
Other$0$0$0$32.97M$17.25M$0$0$28K$0$297K$97K$0$0$0$0
Total Operating Expenses$103.23M$98.05M$99.22M$119.49M$91.67M$48.97M$37.03M$38.41M$52.66M$41.27M$52.12M$50.34M$31.4M$9.58M$8.58M
Operating Income (EBIT)-$103.23M-$98.05M-$99.22M-$119.49M-$91.67M-$48.97M-$37.03M-$42.02M-$52.66M-$41.27M-$52.12M-$50.34M-$31.4M-$9.58M-$8.58M
Operating Margin----------653447.6%-----
Interest Expense$0$0$0$1.04M$0$0$107K$0$0$0$0$0$0$413K$9.25M
Interest Income$1.04M$3.39M$3.08M$1.04M$66K$58K$107K$521K$650K$284K$58K$19K$5K$4K$2K
Other Income (Expense)$6.06M-$2.46M$5.61M-$919K-$1.28M$4.95M$2.1M$455K$577K$297K$97K$2.67M-$1.32M-$40K$2.7M
Income Before Tax (EBT)-$97.17M-$100.51M-$93.61M-$120.41M-$92.94M-$44.02M-$34.93M-$41.48M-$52.08M-$40.97M-$52.02M-$47.67M-$32.72M-$6.7M-$5.88M
Income Tax Expense$0$0$0$0$0$0$0$549K$0$0$0$0$0$413K$0
Net Income-$97.17M-$100.51M-$93.61M-$120.41M-$92.94M-$44.02M-$34.83M-$41.48M-$52.08M-$40.97M-$52.02M-$47.67M-$32.72M-$6.7M-$5.88M
Net Income Margin----------648744.6%-----
Supplementary Data
EPS-6.24-10.03-21.12-37.84-39.30-28.10-45.24-136.28-524.00-524.00-828.00-1416.00-528.14-128.50-107.89
Diluted EPS-6.24-10.03-21.12-37.84-39.30-28.10-45.24-136.28-524.00-524.00-828.00-1416.00-528.14-128.50-107.89
Weighted Average OS15.57M10.02M4.43M3.18M2.37M1.57M772,22684,69599,64778,46862,88240,13659,47659,47659,476
EBITDA-$97M-$100.37M-$93.5M-$86.44M-$92.86M-$48.93M-$36.98M-$14.43M-$51.08M-$39.16M-$50.7M-$46.58M-$31.92M-$5.64M-$7.62M
EBITDA Margin----------620114.9%-----
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Assets
Current Assets
Cash and Cash Equivalents$15.48M$35.67M$46.67M$106.75M$86.86M$127.45M$29.37M$13.32M$56.9M$59.99M$83.42M$102.24M$38.19M$4.48M$803K
Short-Term Investments$0$0$0$9.63M$0$0$0$0$0$0$0$0$0$14M$0
Cash and Short-Term Investments$15.48M$35.67M$46.67M$116.37M$86.86M$127.45M$29.37M$13.32M$56.9M$59.99M$83.42M$102.24M$38.19M$18.47M$803K
Accounts Receivable$4.12M$684K$703K$296K$2.15M$295K$408K$0$0$0$0$0$0$0$0
Inventory$0$0$0$5.61M$0$0-$408K-$191K$0$0$0$0$0$0$0
Other Current Assets$1.2M$1.11M$2.84M$3.59M$1.12M$1.35M$1.55M$0$1.22M$1.47M$533K$1.59M$3.51M$355K$0
Total Current Assets$22.87M$39.33M$52.53M$125.86M$104.99M$133.75M$32.23M$14.23M$58.12M$61.46M$85.09M$104.82M$43.85M$19.15M$889K
Long-Term Assets
Property, Plant & Equipment Net$1.18M$1.54M$1.76M$1.85M$1.1M$1.1M$713K$709K$2.15M$2.5M$3.81M$3.07M$2.47M$1.18M$1.09M
Goodwill$0$0$0$0$32.97M$32.97M$32.97M$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$3.09M$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$43K$42K$42K$42K$37K$108K-$3.03M$184K$198K$263K$0$0
Total Long-Term Assets$1.18M$1.54M$1.76M$1.89M$34.11M$34.12M$33.73M$746K$2.26M$2.56M$3.99M$3.27M$2.73M$1.18M$1.09M
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$24.05M$40.87M$54.3M$127.75M$139.1M$167.86M$65.95M$14.98M$60.38M$64.03M$89.08M$108.08M$46.59M$20.33M$1.98M
Liabilities
Current Liabilities
Accounts Payable$10.14M$7.85M$5.1M$4.28M$3.5M$3.7M$2.42M$268K$1.05M$780K$1.22M$1.15M$1.22M$1.14M$870K
Short-Term Debt$470K$0$0$0$0$0$0$0$0$0$0$0$0$0$534K
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$1.01M$0$0$0$0$0$0$0$0
Other Current Liabilities$20.01M$676K$17.48M$7.33M$851K$82K$343K$564K$5.64M$2.55M$3.27M$6.57M$2.97M$145K$583K
Total Current Liabilities$30.62M$22.18M$24.73M$13.08M$11.4M$8.4M$7.07M$2.51M$10.28M$5.48M$6.66M$10.28M$4.85M$1.75M$2M
Long-Term Liabilities
Long-Term Debt$107K$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities-$107K$0$0$0$0$0$0$41K$59K$100K$101K$241K$321K$26.22M$54.84M
Total Long-Term Liabilities$107K$264K$639K$992K$584K$679K$520K$41K$59K$100K$101K$241K$321K$26.22M$54.84M
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$30.73M$22.44M$25.37M$14.07M$11.98M$9.08M$7.59M$2.55M$10.34M$5.58M$6.76M$10.52M$5.17M$27.96M$56.84M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$37.19M$17.94M$0$0$0$0$0$0
Common Stock$9K$8K$4K$4K$3K$2K$1K$4K$4K$3K$3K$2K$1K$0$0
Retained Earnings-$608.57M-$511.4M-$410.89M-$317.28M-$196.87M-$103.93M-$59.91M-$337.43M-$295.95M-$243.82M-$202.86M$97.56M-$103.17M-$70.45M-$63.75M
Comprehensive Income & Other$2.65M$4.21M$3.76M$3.04M-$252K-$4.11M-$1.37M$80K$78K$83K$80K$89K$96K$88K$83K
Other Stockholders' Equity$601.89M$529.82M$439.82M$430.96M$323.99M$262.71M$118.27M$349.85M$345.99M$302.27M$285.18M-$2K$144.58M$62.82M$8.89M
Total Equity-$6.67M$18.43M$28.93M$113.68M$127.11M$158.78M$58.36M$12.43M$50.04M$58.45M$82.33M$97.56M$41.42M-$7.63M-$54.85M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$24.05M$40.87M$54.3M$127.75M$139.1M$167.86M$65.95M$14.98M$60.38M$64.03M$89.08M$108.08M$46.59M$20.33M$1.98M
Supplementary Data
Total Debt$684K$1M$1.33M$1.56M$992K$976K$520K$37.19M$0$0$0$0$0$0$534K
Net Debt-$14.8M-$34.66M-$45.34M-$105.18M-$85.87M-$126.48M-$28.85M$23.87M-$56.9M-$59.99M-$83.42M-$102.24M-$38.19M-$4.48M-$269K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Operating Activities
Net Income-$97.17M-$100.51M-$93.61M-$120.41M-$92.94M-$44.02M-$34.93M-$41.48M-$52.08M-$40.97M-$52.02M-$47.67M-$32.72M-$6.7M-$5.88M
Depreciation & Amortization$168K$134K$111K$77K$85K$39K$50K$727K$998K$1.81M$1.33M$1.09M$799K$651K$961K
Deferred Income Tax$0$0$0$0$4.33M$0-$355K$1.22M$0$0$0$0$0-$7K$0
Stock-Based Compensation$8.86M$8.53M$7.1M$7.93M$5.95M$2.75M$6.51M$3.74M$5.48M$4.68M$4.03M$2.51M$948K$144K$36K
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$1.24M$3.15M$817K$799K$176K$1M-$462K-$770K$287K-$459K$281K$46K-$91K-$219K-$186K
  Other Working Capital$601K-$2.58M$14.23M$8.73M-$9.46M-$3.37M-$897K-$6.84M$4.66M-$917K-$3.57M$5.78M$1.13M-$254K$82K
Total Working Capital Change$1.84M$564K$15.05M$9.53M-$9.28M-$2.37M-$1.36M-$7.61M$4.95M-$1.38M-$3.29M$5.82M$1.03M-$473K-$104K
Other Non-Cash Items$497K$6.52M$523K$37.73M$8.63M-$2.53M$1.54M$234K$255K$85K$6.68M-$2.58M$1.29M-$2.86M-$2.85M
Net Cash from Operating-$85.81M-$84.77M-$70.83M-$65.14M-$83.23M-$46.12M-$28.55M-$43.16M-$40.4M-$35.77M-$49.95M-$40.83M-$28.65M-$9.24M-$7.83M
Investing Activities
Capital Expenditures-$161K-$264K-$334K-$112K-$67K-$146K-$55K-$597K-$685K-$556K-$2.34M-$1.41M-$1.48M-$261K-$18K
Acquisitions$0$0$0$0$0$0$10.67M$0$7K$2K$0$0$0$0$0
Purchases of Investments$0$0$0-$9.63M$0$0$0$0$0$0$0$0-$3M-$13.99M$0
Sales of Investments$0$0$9.8M$0$0$0$0$0$0$0$0$0$17M$0$0
Other Investing Activities$0$0$0$0$0$0-$75K$182K$7K$535K$1.06M-$631K-$608K-$335K$0
Net Cash from Investing-$161K-$264K$9.46M-$9.74M-$67K-$146K$10.54M-$415K-$678K-$21K-$1.28M-$2.04M$11.91M-$14.59M-$18K
Financing Activities
Debt Repaid--$74.27M------------$6.4M$572K
Common Stock Issuance$65.58M$191K$853K$39.58M$42.75M$144.43M$35.16M$115K$38M$12.36M$32.19M$87.9M$0$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0-$4.74M$0$0$0
Other Financing Activities$0$77K$180K$187K$92K$0-$270K$4K-$14K$19K$232K$5.6M-$2.75M$0-$32K
Net Cash from Financing$65.58M$74.54M$1.03M$95.76M$42.84M$144.43M$34.9M$4K$37.98M$12.37M$32.42M$106.92M$50.45M$27.5M$8.25M
Forex Effect$205K-$517K$262K-$993K-$130K-$78K-$589K-$1K$1K-$4K-$10K-$1K$3K$5K$12K
Net Change in Cash-$20.18M-$11.01M-$60.07M$19.88M-$40.59M$98.08M$16.3M-$43.58M-$3.09M-$23.43M-$18.82M$64.05M$33.71M$3.67M$416K
Supplementary Data
Operating Cash Flow-$85.81M-$84.77M-$70.83M-$65.14M-$83.23M-$46.12M-$28.55M-$43.16M-$40.4M-$35.77M-$49.95M-$40.83M-$28.65M-$9.24M-$7.83M
Capital Expenditure-$161K-$264K-$334K-$112K-$67K-$146K-$55K-$597K-$685K-$556K-$2.34M-$1.41M-$1.48M-$261K-$18K
Free Cash Flow-$85.97M-$85.03M-$71.16M-$65.26M-$83.3M-$46.27M-$28.6M-$43.76M-$41.08M-$36.33M-$52.29M-$42.23M-$30.13M-$9.51M-$7.85M
Cash at Beginning$35.67M$46.67M$106.75M$86.86M$127.45M$29.37M$13.07M$56.9M$59.99M$83.42M$102.24M$38.19M$4.48M$803K$387K
Cash at End$15.48M$35.67M$46.67M$106.75M$86.86M$127.45M$29.37M$13.32M$56.9M$59.99M$83.42M$102.24M$38.19M$4.48M$803K